Henry Chi Hang Fung, MD, FACP, FRCPE

Henry Chi Hang Fung, MD, FRCPE
This physician is not currently rated. Why?

Why is this doctor not rated?


To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings

Request an Appointment

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427
  • Fox Chase–Temple University Hospital Bone Marrow Transplant Program
    Temple University Hospital – Jeanes Campus
    Patient Care Center, Fifth Floor
    7600 Central Avenue
    Philadelphia, PA 19111

Chair, Department of Bone Marrow Transplant and Cellular Therapies

NCCN, Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenstrom's Macroglobulinemia Panel


  • Hematology Oncology
  • Bone Marrow Transplant and Cellular Therapies

Areas of Expertise

Lymphoma, Leukemia, Myeloma


Treatment Philosophy

Cancer treatment and bone marrow transplant represent a journey for my patients and their families, and it’s my sincere privilege to be a part of this experience. I consider us all to be critical members of a cohesive team in making the right decisions to meet my patients’ treatment goals while maintaining quality of life.

Follow on Twitter: @henrychihangfu1

Educational Background

  • Fellow, Hematology/Oncology, Queen Mary Hospital, Hong Kong University, Hong Kong
  • Clinical Fellow, Hematology, Vancouver Hospital and Health Science Center, British Columbia Cancer Control Agency, University of British Columbia, Canada, 1992-1994 
  • Resident, Hematology/Oncology, Queen Mary Hospital, Hong Kong University, 1991-1992
  • Resident, Internal Medicine, Queen Mary Hospital, Hong Kong University, 1988-1991 
  • MBChB, Medicine, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, 1987


  • National Comprehensive Cancer Network (NCCN)
    • Multiple Myeloma/Systemic Light Chain Committee
    • Amyloidosis/Waldenström's Macroglobulinemia Panel
  • American College of Physicians
  • American Society of Hematology
  • American Society of Clinical Oncology
  • American Society of Blood and Marrow Transplantation
  • Royal College of Physicians, Edinburgh, United Kingdom

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2018-20, 2023-2024
  • Best Doctors in America® , 2019-2020, Medical Oncology and Hematology
  • America’s Top Doctors®, 2014-17
  • Fellow, American College of Physicians, 2014
Link to /sites/default/files/styles/patient_story/public/images/patient-stories/Judith%20Bernstein%20Profile.jpg?h=ee3124bd&itok=rIHy7ptb

Judith Bernstein

  • Breast Cancer
  • Lung Cancer
  • Lymphoma
  • Skin Cancer
  • Thyroid Cancer

As a person who has been diagnosed and treated for various types of cancer, I can say with certainty:  Run, don’t walk, to Fox Chase Cancer Center. I have given this piece of advice more times than I can count because I know that where you begin your cancer treatment really does matter.


Research Interests

  • Allogeneic stem cell transplantation using alternative donors
  • Treatment and stem cell transplantation for multiple myeloma, lymphoma and leukemias, myelodysplasia, myeloproliferative disease and myelofibrosis

Selected Publications

Syed A. Abutalib, Kieron Dunleavy & Henry C. Fung: Primary Mediastinal B Cell Lymphoma. In Clinical Oncology (In Press).

Henry C Fung, Philip Pancari and Patricia Kropf. Primary Central Nervous System Lymphoma. In Clinical Manual of Blood & Marrow Hematopoietic Cell Transplantation. Edited by Dr. Syed A. Abutalib & Dr. Parameswaran Hari (In Press).

Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma.: A Goy, M Berger, P Ford, T Feldman, A Mato, C Bejot and Henry C Fung - Leukemia & lymphoma, 2014/12. PubMed

Gastrointestinal Side Effects and Adequacy of Enteral Intake in Hematopoietic Stem Cell Transplant Patients: M Walrath, C Bacon, S Foley, HC Fung - Nutrition in Clinical Practice, 2014/9. PubMed

Anger, provider responses, and pain: Prospective analysis of stem cell transplant patients: JI Gerhart, V Sanchez Varela, JW Burns, SE Hobfoll, HC Fung; Health Psychology 34 (3), 197. PubMed

Posttraumatic stress symptoms predict impaired neutrophil recovery in stem cell transplant recipients: SE Hobfoll, JI Gerhart, AK Zalta, K Wells, J Maciejewski and Henry C Fung- Psycho‐Oncology, 2015.   PubMed

Evaluating Neutropenia Recovery in Patients Receiving Filgrastim on Day+ 5 Versus Day+ 10 Post Autologous Hematopoietic Stem Cell Transplant: LM DiGrazia, M Janusek, K Schultz, L Geswein, HC Fung; Journal of Oncology Pharmacy Practice (in press).

Peksa GD, Schultz K, Fung HC: Dosing Algorithm for Concomitant Administration of Sirolimus, Tacrolimus, and an Azole After Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Oncology Pharmacy Practice.  2014 June 17: pii:1078155214539625. [Epub ahead of print]. PubMed

Christopherson KW 2nd, Frank R, Jagan S, Paganessi LA, Rizman A, Gezer S, Gregory SA, Fung HC: CD26 Protease Inhibition Improves Functional Response of Un-fractionated Mobilized Peripheral Blood Mononuclear Cells to CXCL12/SDF-1. Exp Hematol 2012 Nov;40(11):945-52.doi:10.1016/j.exphem.2012.07.009. Epub 2012 Jul 27. PubMed

Tuncer HH, Gregory SA, Fung HC: High-Dose Chemotherapy with Autologous Stem Cell Rescue for Relapse after Allo-SCT in Multiple Myeloma: A Case Report. Bone Marrow Transplant Oct 2010. PubMed

 Krishnan A, Nademanee A, Fung HC, Raubitschek AA, Molina A, Yamauchi D, Rodriguez R, Spielberger RT, Falk P, Palmer JM, Forman SJ: Phase II trial of a Transplantation Regimen of Yttrium-90 Ibritumomab Tiuxetan and High-Dose Chemotherapy in Patients with Non-Hodgkin’s Lymphoma. Journal of clinical Oncology 2008 Jan 1;26(1):90-5. Epub 2007 Nov 19. PubMed

Fung HC, Stif P, Schriber J, Toor A, Smith E, Rodriguez T, Krishnan A, Molina A, Smith D, Ivers, Kogut N, Popplewell L, Rodriguez R, Somlo G, Forman SJ, Nademanee A:. Tandem Autologous Stem Cell Transplantation for Patients with Primary Refractory or Poor Risk Recurrent Hodgkin Lymphoma. Biol Blood Marrow Transplant 2007 May;13(5):594-600. Epub 2007 Mar 23. PubMed

Sahebi F, Spielberger R, Kogut NM, Fung HC, et al.:  Maintenance Thalidomide Following Single Cycle Autologous Peripheral Blood Stem Cell Transplant in Patients with Multiple Myeloma. Bone Marrow Transplantation 2006 May;37(9):825-9. PubMed

Henry C Fung MBchB, FRCPE, Sunita Nathan MD, John J Maciejewski MD, PhD: Induction Chemotherapy Before Autologous Stem Cell Transplantation for Patients with Symptomatic Plasma Cell Myeloma----does it matter? Clinical Pharmacology: Advances and Applications (2010).  PubMed

A.M. Jimenez, Henry C Fung and Kent Chistopherson II: Strategies for Improving Transplant Efficiency in the Context of Cellular Therapeutics.  Transfusion 2011 Nov; 51 Suppl 4: 125S-137S.  doi: 10.1111/j. 1537-2995.2001.03375.x.   PubMed

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...